INARI MEDICAL (NASDAQ: NARI): Kaplan Fox Encourages Inari Medical, Inc Investors with Significant Losses to Contact the Firm

NEW YORK, NY - (NewMediaWire) - March 6, 2024 - Kaplan Fox & Kilsheimer LLP ( is investigating claims on behalf of investors of Inari Medical, Inc. (“Inari Medical” or the “Company”) (NASDAQ: NARI). Click Here to Join Investigation.

If you acquired Inari Medical shares and would like to discuss our investigation, please click here or contact us by emailing or by calling (646) 315-9003.

On February 28, 2024, after the market close, Inari Medical announced that the Company had received a civil investigative demand in December 2023 from the U.S. Department of Justice (“DOJ”) in connection with an investigation under the federal Anti-Kickback Statute and Civil False Claims Act related to payments made to healthcare professionals.    During the Company conference call that followed, Inari’s Chief Financial Officer stated that the DOJ is “primarily requesting information related to meals and consulting service payments provided to healthcare professionals.”

Following this news, Inari Medical's stock fell $12.14 per share, or 20.8%, to close at $46.12 on February 29, 2024.

WHY CONTACT KAPLAN FOX - Kaplan Fox is a leading national law firm focusing on complex litigation with offices in New York, Oakland, Los Angeles, Chicago and New Jersey.  With over 50 years of experience in securities litigation, Kaplan Fox offers the professional experience and track record that clients demand.  Through prosecuting cases on the federal and state levels, Kaplan Fox has successfully shaped the law through winning many important decisions on behalf of our clients.  For more information about Kaplan Fox & Kilsheimer LLP, you may visit our website at

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

If you have any questions about this investigation, please contact:

Pamela A. Mayer

800 Third Avenue, 38th Floor
New York, New York 10022
(646) 315-9003


Laurence D. King
1999 Harrison Street, Suite 1560
Oakland, California 94612
(415) 772-4704
Fax:  (415) 772-4707

Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.